Vaccine Research At Bavarian Nordic A/S Pharmaceuticals

A visitor passes the reception area at the headquarters of the Bavarian Nordic A/S biotechnology company, where the research into infectious diseases, including the ebola vaccine, takes place in Kvistgaard, Denmark, on Friday, Oct. 31, 2014. The ebola vaccine combines a shot from Johnson & Johnson's Janssen unit in the Netherlands with one developed by Bavarian Nordic, the U.S.-based company said. Photographer: Freya Ingrid Morales/Bloomberg via Getty Images
A visitor passes the reception area at the headquarters of the Bavarian Nordic A/S biotechnology company, where the research into infectious diseases, including the ebola vaccine, takes place in Kvistgaard, Denmark, on Friday, Oct. 31, 2014. The ebola vaccine combines a shot from Johnson & Johnson's Janssen unit in the Netherlands with one developed by Bavarian Nordic, the U.S.-based company said. Photographer: Freya Ingrid Morales/Bloomberg via Getty Images
Vaccine Research At Bavarian Nordic A/S Pharmaceuticals
ACQUISTA UNA LICENZA
Come posso utilizzare questa immagine?
475,00 €
EUR

DETTAGLI

Restrizioni:
Contatta l'ufficio locale per informazioni su qualsiasi tipo di uso commerciale o promozionale.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Attestazione:
Bloomberg / Collaboratore
N. Editorial:
458176764
Collezione:
Bloomberg
Data di creazione:
31 ottobre 2014
Data di upload:
Tipo di licenza:
Rights-managed
Info sulla liberatoria:
Senza liberatoria. Ulteriori informazioni
Fonte:
Bloomberg
Nome oggetto:
DENMARK PHARMA
Max. dimensione file:
4000 x 2667 px (33,87 x 22,58 cm) - 300 dpi - 2 MB